We also observed that genetic deletion or pharmacological inhibition of hypothalamic PDK2 significantly reduced diabetes-induced inflammatory markers and food intake associated with an increase in orexigenic neuropeptide and decreased anorexigenic neuropeptide expression. The gene discussed is PDK2; the disease is diabetes mellitus.